The Role of Phospholipase C in GABAergic Inhibition and Its Relevance to Epilepsy.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Mar 2021
Historique:
received: 29 11 2020
revised: 02 03 2021
accepted: 17 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 29 4 2021
Statut: epublish

Résumé

Epilepsy is characterized by recurrent seizures due to abnormal hyperexcitation of neurons. Recent studies have suggested that the imbalance of excitation and inhibition (E/I) in the central nervous system is closely implicated in the etiology of epilepsy. In the brain, GABA is a major inhibitory neurotransmitter and plays a pivotal role in maintaining E/I balance. As such, altered GABAergic inhibition can lead to severe E/I imbalance, consequently resulting in excessive and hypersynchronous neuronal activity as in epilepsy. Phospholipase C (PLC) is a key enzyme in the intracellular signaling pathway and regulates various neuronal functions including neuronal development, synaptic transmission, and plasticity in the brain. Accumulating evidence suggests that neuronal PLC is critically involved in multiple aspects of GABAergic functions. Therefore, a better understanding of mechanisms by which neuronal PLC regulates GABAergic inhibition is necessary for revealing an unrecognized linkage between PLC and epilepsy and developing more effective treatments for epilepsy. Here we review the function of PLC in GABAergic inhibition in the brain and discuss a pathophysiological relationship between PLC and epilepsy.

Identifiants

pubmed: 33808762
pii: ijms22063149
doi: 10.3390/ijms22063149
pmc: PMC8003358
pii:
doi:

Substances chimiques

Anticonvulsants 0
Biomarkers 0
GABA Antagonists 0
Isoenzymes 0
Receptors, GABA 0
gamma-Aminobutyric Acid 56-12-2
Type C Phospholipases EC 3.1.4.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Research Foundation of Korea
ID : 2020R1A2C1005492

Références

Neurol Clin. 1986 Aug;4(3):617-32
pubmed: 3528811
Nat Genet. 2002 Jun;31(2):184-9
pubmed: 11992121
Eur J Neurosci. 2001 Apr;13(7):1320-8
pubmed: 11298792
Epilepsy Behav. 2017 Jun;71(Pt B):165-173
pubmed: 26254980
Trends Pharmacol Sci. 2018 Aug;39(8):710-732
pubmed: 29903580
Neuron. 2015 Nov 4;88(3):484-91
pubmed: 26481038
Mol Psychiatry. 2018 Sep;23(9):1851-1867
pubmed: 29904150
J Neurosci. 2003 Sep 3;23(22):8098-108
pubmed: 12954872
J Comp Neurol. 2007 Jul 20;503(3):466-85
pubmed: 17503488
J Neurosci. 2010 Jan 13;30(2):749-59
pubmed: 20071540
Epilepsy Res. 1992 Jul;12(2):75-86
pubmed: 1396543
Seizure. 2011 Jun;20(5):359-68
pubmed: 21292505
J Neurochem. 1977 Apr;28(4):717-23
pubmed: 894280
Neuron. 2009 Mar 26;61(6):820-38
pubmed: 19323993
Front Synaptic Neurosci. 2010 Jun 07;2:4
pubmed: 21423490
J Neurosci. 1998 Oct 15;18(20):8505-14
pubmed: 9763493
J Neurosci. 1997 May 1;17(9):2959-66
pubmed: 9096132
J Child Neurol. 2007 Apr;22(4):414-8
pubmed: 17621520
Am J Hum Genet. 2015 May 7;96(5):808-15
pubmed: 25865495
Curr Opin Pharmacol. 2007 Feb;7(1):56-61
pubmed: 17055336
J Biochem. 2017 Apr 1;161(4):315-321
pubmed: 28130414
Neuropharmacology. 2008 Nov;55(6):961-8
pubmed: 18640136
Neurochem Res. 2017 Jul;42(7):1873-1888
pubmed: 28290134
Exp Neurol. 1986 Jul;93(1):145-59
pubmed: 3732456
Glia. 2006 Sep;54(4):258-71
pubmed: 16845674
Eur J Paediatr Neurol. 2016 May;20(3):474-9
pubmed: 26818157
Psychopharmacology (Berl). 1982;76(1):84-7
pubmed: 6281839
Brain Res Bull. 1994;35(5-6):493-504
pubmed: 7859107
J Neurosci Res. 2005 Mar 1;79(5):616-27
pubmed: 15672445
Neuron. 2015 Aug 19;87(4):684-98
pubmed: 26291155
Adv Neurol. 1986;44:303-18
pubmed: 2871721
Brain Res. 2008 Jul 11;1219:19-25
pubmed: 18539266
Epilepsia. 2012 Dec;53 Suppl 8:12-25
pubmed: 23205959
Mol Neurobiol. 2001 Feb;23(1):69-82
pubmed: 11642544
Trends Pharmacol Sci. 2008 Sep;29(9):454-64
pubmed: 18676031
Mol Psychiatry. 2019 Sep;24(9):1248-1257
pubmed: 31089192
Cereb Cortex. 1993 Sep-Oct;3(5):361-72
pubmed: 8260806
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13311-6
pubmed: 9371842
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):14060-5
pubmed: 9391152
Epilepsia. 2001;42 Suppl 3:8-12
pubmed: 11520315
Neuroscience. 2006 Sep 15;141(4):2177-94
pubmed: 16797850
Prog Neurobiol. 1990;35(4):245-96
pubmed: 1980745
Adv Biol Regul. 2013 Jan;53(1):51-62
pubmed: 23063587
Biochemistry. 2000 Jul 25;39(29):8674-82
pubmed: 10913276
J Neurosci Methods. 2008 Jul 30;172(2):143-57
pubmed: 18550176
Neuron. 1998 Jun;20(6):1211-8
pubmed: 9655508
Dev Med Child Neurol. 1995 Aug;37(8):682-8
pubmed: 7672465
Front Cell Neurosci. 2019 Nov 15;13:515
pubmed: 31803025
Front Cell Neurosci. 2013 Aug 30;7:139
pubmed: 24009559
Mol Psychiatry. 1998 Nov;3(6):534-8
pubmed: 9857980
BMB Rep. 2008 Jun 30;41(6):415-34
pubmed: 18593525
EMBO Rep. 2018 Nov;19(11):
pubmed: 30224412
Nat Neurosci. 2015 Mar;18(3):344-50
pubmed: 25710836
Nat Rev Drug Discov. 2013 Oct;12(10):757-76
pubmed: 24052047
JAMA Neurol. 2018 Mar 1;75(3):279-286
pubmed: 29279892
Neural Plast. 2016;2016:8607038
pubmed: 27006834
Epilepsia. 1976 Sep;17(3):321-4
pubmed: 824124
Paediatr Perinat Drug Ther. 2006 May;7(1):31-42
pubmed: 17356688
Epilepsia. 2012 Aug;53(8):e146-50
pubmed: 22690784
Front Neurosci. 2018 Feb 02;12:46
pubmed: 29456491
Br J Clin Pharmacol. 1989;27 Suppl 1:109S-112S
pubmed: 2757901
J Biol Chem. 2003 Nov 7;278(45):44097-102
pubmed: 12941963
Psychiatr Genet. 2001 Mar;11(1):41-3
pubmed: 11409699
Epileptic Disord. 2011 Dec;13(4):349-65
pubmed: 21926048
Nat Genet. 2001 May;28(1):49-52
pubmed: 11326275
Lancet. 2015 Mar 7;385(9971):884-98
pubmed: 25260236
Mol Psychiatry. 2017 Oct;22(10):1473-1482
pubmed: 28138157
Mol Cell Neurosci. 2002 Dec;21(4):584-601
pubmed: 12504592
Lancet Neurol. 2019 Apr;18(4):357-375
pubmed: 30773428
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14598-601
pubmed: 8962098
J Physiol. 2003 May 1;548(Pt 3):703-9
pubmed: 12640007
Nat Rev Neurosci. 2004 Jul;5(7):553-64
pubmed: 15208697
Biochem J. 1991 Apr 15;275 ( Pt 2):435-9
pubmed: 1902665
Biochem Biophys Res Commun. 1996 Dec 24;229(3):891-5
pubmed: 8954991
Mol Brain. 2010 Dec 30;3:40
pubmed: 21190592
Nature. 1967 Jun 3;214(5092):1020-1
pubmed: 6055396
Exp Neurol. 1969 Nov;25(3):295-330
pubmed: 4981856
Epilepsy Res. 2008 Dec;82(2-3):111-23
pubmed: 18774262
Neuroscience. 2014 Nov 7;280:254-61
pubmed: 25241062
Neuroscience. 1985 Feb;14(2):375-403
pubmed: 2859548
Epilepsia. 1991 Mar-Apr;32(2):168-73
pubmed: 2004621
Heliyon. 2020 Jul 28;6(7):e04557
pubmed: 32775726
J Neurosci. 2009 Jan 14;29(2):371-80
pubmed: 19144837
J Neurosci. 2010 Feb 3;30(5):1750-9
pubmed: 20130184
Exp Neurobiol. 2017 Jun;26(3):122-131
pubmed: 28680297
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21912-7
pubmed: 19955421
Adv Biol Regul. 2016 May;61:80-5
pubmed: 26639088
Nat Neurosci. 2015 Mar;18(3):339-43
pubmed: 25710835
J Neurochem. 1980 Jun;34(6):1603-8
pubmed: 7381487
J Neurosci. 2010 May 5;30(18):6188-96
pubmed: 20445044
Exp Cell Res. 2003 Sep 10;289(1):184-94
pubmed: 12941616
J Pharmacol Exp Ther. 1981 May;217(2):445-50
pubmed: 6785416
Seizure. 2013 Oct;22(8):589-600
pubmed: 23683707
J Neurosci. 2003 Dec 10;23(36):11382-91
pubmed: 14673002
Mol Ther Methods Clin Dev. 2019 Jan 08;13:180-186
pubmed: 30788386
Nature. 2014 Jul 31;511(7511):596-600
pubmed: 25043046
Front Neurol. 2020 Jan 17;10:1407
pubmed: 32010056
J Neurosci. 2002 Sep 1;22(17):7580-5
pubmed: 12196581
Epilepsia. 2014 Mar;55(3):456-63
pubmed: 24502564
Hippocampus. 2003;13(5):633-45
pubmed: 12921352
Seizure. 2017 Jan;44:11-20
pubmed: 28007376
Schizophr Res. 2011 May;128(1-3):37-43
pubmed: 21303731
Pharmacol Rev. 2016 Jul;68(3):563-602
pubmed: 27255267
J Neurochem. 2016 Feb;136(3):526-35
pubmed: 26484945
Adv Biol Regul. 2013 Sep;53(3):232-41
pubmed: 24041464
Nat Rev Neurosci. 2013 May;14(5):337-49
pubmed: 23595016
Hippocampus. 2008;18(8):824-34
pubmed: 18493969
J Neurosci. 2004 May 12;24(19):4683-91
pubmed: 15140939
Mol Cell Neurosci. 2001 Jun;17(6):1059-70
pubmed: 11414794
Proc Jpn Acad Ser B Phys Biol Sci. 2018;94(10):390-411
pubmed: 30541966
Trends Neurosci. 2001 Jan;24(1):47-53
pubmed: 11163887
Nat Rev Neurosci. 2007 Jun;8(6):451-65
pubmed: 17514198
Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10385-90
pubmed: 10468617
Nat Rev Neurosci. 2008 May;9(5):331-43
pubmed: 18382465
J Comp Neurol. 1999 Sep 27;412(3):488-505
pubmed: 10441235
J Biol Chem. 2012 Nov 23;287(48):40224-31
pubmed: 23038269
J Am Vet Med Assoc. 1998 Nov 15;213(10):1449-53
pubmed: 9828942
Curr Treat Options Neurol. 2016 Apr;18(4):18
pubmed: 26923608
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2887-99
pubmed: 24184743
Neurochem Int. 2014 Mar;68:10-7
pubmed: 24480781
Neuropsychiatr Dis Treat. 2008 Aug;4(4):731-6
pubmed: 19043517
Epilepsia. 2002;43 Suppl 5:37-9
pubmed: 12121293
Neuron. 2004 Jul 8;43(1):31-42
pubmed: 15233915
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6496-9
pubmed: 9177246
J Physiol. 2013 Feb 15;591(4):823-33
pubmed: 23090943
Physiol Rev. 2004 Jul;84(3):835-67
pubmed: 15269338
Epilepsia. 2010 Aug;51(8):1468-76
pubmed: 20477846
Neurosci Lett. 2003 Jan 2;335(3):207-11
pubmed: 12531468
Neuroscience. 2018 Feb 21;372:74-86
pubmed: 29292080
Epilepsia. 2006 Oct;47(10):1655-64
pubmed: 17054688
Brain. 2018 Aug 1;141(8):2392-2405
pubmed: 29961870
Cereb Cortex. 2009 Jan;19(1):241-8
pubmed: 18502731
Trends Neurosci. 2008 Jul;31(7):317-27
pubmed: 18556072
J Vet Pharmacol Ther. 1985 Jun;8(2):113-9
pubmed: 4020942
Front Mol Neurosci. 2008 Mar 28;1:5
pubmed: 18946538
Neuropharmacology. 2010 Jun;58(7):1179-86
pubmed: 20206640
Neuropsychiatr Dis Treat. 2014 Sep 09;10:1693-705
pubmed: 25228809
Arzneimittelforschung. 1984;34(10):1261-4
pubmed: 6542784
Brain. 2010 Oct;133(10):2964-70
pubmed: 20833646
Nat Rev Neurosci. 2012 May 18;13(6):380-94
pubmed: 22595784
J Neurosci. 1994 Mar;14(3 Pt 2):1834-55
pubmed: 8126575
Neuron. 2001 Jul 19;31(1):47-58
pubmed: 11498050
Neurology. 2003 Feb 25;60(4):560-3
pubmed: 12601092
Nature. 1997 Sep 18;389(6648):290-3
pubmed: 9305844
Front Psychiatry. 2017 Aug 11;8:118
pubmed: 28848455
Neurochem Res. 2003 Feb;28(2):333-40
pubmed: 12608706
Epilepsy Curr. 2005 May-Jun;5(3):83-8
pubmed: 16145610
Hippocampus. 2000;10(3):305-24
pubmed: 10902900
Life Sci. 1986 Sep 1;39(9):775-82
pubmed: 3747729
J Neurophysiol. 2007 Aug;98(2):952-65
pubmed: 17581851
J Neurochem. 2011 Aug;118(4):533-45
pubmed: 21255015
Hippocampus. 2012 Mar;22(3):590-603
pubmed: 21509853
J Neurosci. 2009 Sep 16;29(37):11650-61
pubmed: 19759312
J Physiol. 2016 May 15;594(10):2593-605
pubmed: 26876607
Clin Genet. 2020 Mar;97(3):477-482
pubmed: 31883110
Behav Brain Res. 1983 Sep;9(3):315-35
pubmed: 6639740
J Neural Transm Suppl. 1992;35:37-69
pubmed: 1512594
Neuropharmacology. 2020 May 15;168:107966
pubmed: 32120063
FASEB J. 1995 May;9(8):619-25
pubmed: 7768353
Neurosci Biobehav Rev. 2012 Oct;36(9):2044-55
pubmed: 22841562
Epilepsia. 1989 Sep-Oct;30(5):603-6
pubmed: 2507306
Sci Rep. 2019 Nov 28;9(1):17761
pubmed: 31780806
Drugs. 1977 Feb;13(2):81-123
pubmed: 402258
Neurosci Res. 2004 Nov;50(3):319-29
pubmed: 15488295
Curr Opin Pharmacol. 2015 Feb;20:83-8
pubmed: 25506747
Br J Pharmacol. 2006 Aug;148(7):984-90
pubmed: 16783415
Epilepsy Res. 1987 Sep;1(5):297-301
pubmed: 3143552
BMB Rep. 2011 Sep;44(9):566-71
pubmed: 21944248

Auteurs

Hye Yun Kim (HY)

Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.

Pann-Ghill Suh (PG)

Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.
Korea Brain Research Institute (KBRI), Daegu 41062, Korea.

Jae-Ick Kim (JI)

Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH